HKD 20.5
(-3.76%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -366.57 Million USD | 9.34% |
2022 | -404.35 Million USD | 42.24% |
2021 | -700.06 Million USD | -131.96% |
2020 | -301.8 Million USD | -48.53% |
2019 | -203.19 Million USD | -43.33% |
2018 | -141.76 Million USD | -175.86% |
2017 | -51.39 Million USD | -33.38% |
2016 | -38.52 Million USD | -135.66% |
2015 | -16.34 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -76.06 Million USD | -8.19% |
2024 Q1 | -70.3 Million USD | 43.29% |
2023 Q3 | -83.57 Million USD | 6.63% |
2023 Q2 | -89.5 Million USD | -28.74% |
2023 FY | -366.57 Million USD | 9.34% |
2023 Q1 | -69.52 Million USD | 28.54% |
2023 Q4 | -123.98 Million USD | -48.36% |
2022 Q1 | -79.76 Million USD | 63.61% |
2022 FY | -404.35 Million USD | 42.24% |
2022 Q4 | -97.29 Million USD | 24.33% |
2022 Q3 | -128.58 Million USD | -30.26% |
2022 Q2 | -98.71 Million USD | -23.76% |
2021 FY | -700.06 Million USD | -131.96% |
2021 Q2 | -170.57 Million USD | 24.89% |
2021 Q3 | -83.2 Million USD | 51.22% |
2021 Q4 | -219.19 Million USD | -163.44% |
2021 Q1 | -227.09 Million USD | -138.4% |
2020 Q2 | -83.96 Million USD | -81.27% |
2020 Q3 | -76.25 Million USD | 9.18% |
2020 FY | -301.8 Million USD | -48.53% |
2020 Q4 | -95.25 Million USD | -24.91% |
2020 Q1 | -46.32 Million USD | 11.0% |
2019 Q2 | -42.93 Million USD | 0.0% |
2019 FY | -203.19 Million USD | -43.33% |
2019 Q4 | -52.04 Million USD | 20.25% |
2019 Q3 | -65.26 Million USD | -52.0% |
2019 Q1 | -42.93 Million USD | 35.47% |
2018 Q1 | -20.49 Million USD | -54.84% |
2018 Q2 | -20.49 Million USD | 0.0% |
2018 Q3 | -34.22 Million USD | -66.98% |
2018 Q4 | -66.54 Million USD | -94.41% |
2018 FY | -141.76 Million USD | -175.86% |
2017 FY | -51.39 Million USD | -33.38% |
2017 Q1 | -12.45 Million USD | 8.98% |
2017 Q2 | -12.45 Million USD | 0.0% |
2017 Q3 | -13.23 Million USD | -6.27% |
2017 Q4 | -13.23 Million USD | 0.0% |
2016 Q4 | -13.68 Million USD | 0.0% |
2016 Q3 | -13.68 Million USD | -145.39% |
2016 Q1 | -5.57 Million USD | 0.0% |
2016 Q2 | -5.57 Million USD | 0.0% |
2016 FY | -38.52 Million USD | -135.66% |
2015 FY | -16.34 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 67.76 Million HKD | 640.923% |
CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 140.823% |